Literature DB >> 209465

Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay.

R C Mellors, J W Mellors.   

Abstract

Postmortem study of proliferative glomerulonephritis associated with human systemic lumpus has previously shown that an antigen related to mammalian type C RNA viral core (p30) proteins is deposited in the renal glomerular lesions with human immunoglobulins in an immune-complex pattern. In the present work, human immunoglobulins were sequentially eluted from the lupus glomerular immune deposits and were assayed by a sensitive enzymoimmunoassay developed for the measurement of anti-p30 antibody activity against purified viral p30 proteins of mammalian type C viruses. Human immunoglobulins showing specific anti-p30 antibody activity, particularly against p30 antigen of feline endogenous virus RD-114 and to a smaller extent against p30 antigen of murine type C virus, were eluted by acid buffer from the glomerular immune deposits in two patients with lupus proliferative glomerulonephritis who have deposits of viral p30-related antigen in the same tissue lesions. This study adds support for the hypothesis that expression of type C viral antigen may be involved in the multifactorial pathogenesis of proliferative glomerulonephritis associated with human systemic lupus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209465      PMCID: PMC392574          DOI: 10.1073/pnas.75.5.2463

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  SPECIFIC COMPLEMENT-FIXING VIRAL ANTIGENS IN HAMSTER AND GUINEA PIG TUMORS INDUCED BY THE SCHMIDT-RUPPIN STRAIN OF AVIAN SARCOMA.

Authors:  R J HUEBNER; D ARMSTRONG; M OKUYAN; P S SARMA; H C TURNER
Journal:  Proc Natl Acad Sci U S A       Date:  1964-05       Impact factor: 11.205

2.  Failure to detect, in human sera, antibodies cross-reactive with group-specific antigens of murine leukemia virus.

Authors:  H P Charman; N Kim; M White; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

3.  Evolution of type C viral genes: I. Nucleic acid from baboon type C virus as a measure of divergence among primate species.

Authors:  R E Benveniste; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

4.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

5.  Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen.

Authors:  J C Sutherland; M R Mardiney
Journal:  J Natl Cancer Inst       Date:  1973-03       Impact factor: 13.506

6.  Natural human antibodies reactive with primate type-C viral antigens.

Authors:  R Kurth; N M Teich; R Weiss; R T Oliver
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  Type-C RNA virus gene expression in human tissue.

Authors:  M Strand; J T August
Journal:  J Virol       Date:  1974-12       Impact factor: 5.103

8.  Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells.

Authors:  R E Gallagher; R C Gallo
Journal:  Science       Date:  1975-01-31       Impact factor: 47.728

9.  Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses.

Authors:  H W Snyder; T Pincus; E Fleissner
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

10.  Antibodies in human sera to oncorna virus-like proteins from normal or leukemia marrow cell cultures.

Authors:  S Louie; J E Curtis; J E Till; E A McCulloch
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  13 in total

1.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 2.  HEL-12 virus: general considerations.

Authors:  S Panem
Journal:  Surv Immunol Res       Date:  1983

3.  Detection and quantification of type C viral proteins in tissues and sera with an enzyme immunoassay.

Authors:  H Schetters; R Hehlmann; V Erfle; M Ramanarayanan
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 4.  Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease.

Authors:  H B Urnovitz; W H Murphy
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

5.  Particle-bound DNA polymerase activity in haematological disorders and normal controls.

Authors:  G N van Muijen; J te Velde; R Willemze; F E Zwaan; S O Warnaar
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

6.  The presence of antibodies to purified p24gag protein of HTLV-I in sera of patients with systemic lupus erythematosus (SLE).

Authors:  J Higashi; S Kumagai; M Hatanaka; H Imura
Journal:  Virus Genes       Date:  1992-11       Impact factor: 2.332

7.  Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas.

Authors:  L B Jerabek; R C Mellors; K B Elkon; J W Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  Evidence in patients with systemic lupus erythematosus of the presence of antibodies against RNA-dependent DNA polymerase of baboon endogenous virus.

Authors:  T Okamoto; T Tamura; T Takano
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

Review 9.  RNA-tumorviruses, oncogenes, and their possible role in human carcinogenesis.

Authors:  R Hehlmann; H Schetters; G Kreeb; V Erfle; J Schmidt; A Luz
Journal:  Klin Wochenschr       Date:  1983-12-15

Review 10.  Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.

Authors:  Andras Perl; Gyorgy Nagy; Agnes Koncz; Peter Gergely; David Fernandez; Edward Doherty; Tiffany Telarico; Eduardo Bonilla; Paul E Phillips
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.